WHO ICTRP trial
Heparin dose (300 IU/kg vs. 600 IU/kg) in coroanry artery bypass grafting
EUCTR2012-000449-11-FI · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2012-000449-11-FI |
|---|---|
| Public title | Heparin dose (300 IU/kg vs. 600 IU/kg) in coroanry artery bypass grafting |
| Scientific title | Heparin dose (300 IU/kg vs. 600 IU/kg) in coroanry artery bypass grafting |
| Primary sponsor | Eero Pesonen |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): yes |
| Countries | Finland |
| Conditions | Patients undergoing elective coronary artery bypass grafting MedDRA version: 21.1 Level: LLT Classification code 10068176 Term: Coronary artery bypass graft System Organ Class: 100000004865 ;Therapeutic area: Analytical, Diagnostic and… |
| Interventions | Trade Name: Heparin LEO 5000 IE/KY/ml injektioneste Product Name: Heparin LEO 5000 IE/KY/ml Pharmaceutical Form: Solution for injection |
| Registration date | Jun 2, 2012 |
| Target size | 200 |
| Secondary IDs | EP250567 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: